| Literature DB >> 27343073 |
Yong Keun Park1, Jee Eun Choi2, Woon Yong Jung3, Sung Kyu Song1, Jong In Lee1, Chul-Woon Chung4.
Abstract
BACKGROUND: Biliary strictures at the hilum of the liver arise from heterogeneous etiologies. The majority is malignant entities, but some may have benign etiologies. It is difficult to distinguish between malignant and benign biliary strictures preoperatively. It has been reported that 5~15 % of preoperative diagnoses of hilar cholangiocarcinoma turn out to be benign lesions or even other types of malignancies. Primary non-Hodgkin's lymphoma of the extrahepatic bile duct is very rare, with only a few cases reported as mucosa-associated lymphoid tissue (MALT) lymphoma arising from the hepatic duct bifurcation. We herein report a case of a female patient presenting with perihilar bile ducts obstructed by primary MALT lymphoma resembling hilar cholangiocarcinoma, along with a review of the literature. CASEEntities:
Keywords: B cell lymphoma; Hilar cholangiocarcinoma; Klatskin tumor; Magnetic resonance cholangio-pancreatography
Mesh:
Year: 2016 PMID: 27343073 PMCID: PMC4919877 DOI: 10.1186/s12957-016-0928-z
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Fig. 1Preoperative computed tomographic (a) and gross (b) findings. a Diffuse dilatation of the intrahepatic duct and wall thickening of the common bile duct were shown. b Wall thickening with focal mass was found without complete obstruction by mass
Fig. 2Microscopic findings of resected tumor. a The common bile duct showed diffuse infiltration of lymphoid cells forming lymphoid follicles. The glands at the mucosal surface were extensively eroded by lymphocytic infiltration (hematoxylin-eosin (HE) ×40). b The neoplastic lymphocytes occasionally infiltrated into the glandular epithelium (lymphoepithelial lesion; HE ×400)
Fig. 3Immunohistochemical staining. a CD20 immunohistochemical stain revealed diffuse infiltration of B cells (CD20 ×100). b BCL2-positive neoplastic cells surrounded reactive germinal centers containing proliferating B cells (BCL2 ×200) (c), which were highlighted by Ki-67 (Ki-67 ×100). d Immunohistochemical staining results for cyclin D1 protein were negative (cyclin D1 ×100)
Summary of cases of primary mucosa-associated lymphoid tissue lymphoma resembling Klatskin tumor
| Case | Author, year | Age/sex | Radiologic findings | Surgical findings | Treatment |
|---|---|---|---|---|---|
| 1 | Shimura et al. [ | 59/male | Irregular, incomplete stenosis from hilum to the lower part of the bile duct | Mass (4.5 × 3.5 cm) around the EHD | Right trisegmentectomy + caudate lobectomy |
| 2 | Shito et al. [ | 71/male | Dilatation of IHD with a circumscribed heterogeneous mass in the main hepatic junction | Dense, white, nodular mass (5.0 × 2.5 cm) in the main hepatic junction | Left hemihepatectomy + caudate lobectomy + radical bile duct resection + Roux-en-Y hepaticojejunostomy + chemotherapy (CHOP, 3 cycles) |
| 3 | Yoon et al. [ | 62/male | Dilatation of IHD with long, segmental, circumferential wall thickening of entire extrapancreatic portion of CBD + cystic duct + right posterior, anterior segmental IHD + left secondary biliary confluence | Diffuse wall thickening of EHD with smooth inner and outer surface without mass lesion | Right hemihepatectomy + caudate lobectomy + radical bile duct resection + Roux-en-Y hepaticojejunostomy + chemotherapy (CVP, 6 cycles) |
| 4 | MiKail et al. [ | 58/female | Dilatation of IHD with a mass at liver hilus with intrahepatic biliary dilatation | 4 cycles of R-CHOP (rituximab/cyclophosphamide/doxorubicine/vincristine/prednisolone) | |
| 5 | This case | 86/female | Diffuse dilatation of IHD and wall thickening of CHD | Intraluminal mass in the proximal CBD and on the duodenal side, a spreading tumor-like lesion | Radical bile duct resection + Roux-en-Y hepaticojejunostomy |
MALT mucosa-associated lymphoid tissue, IHD intrahepatic bile duct, EHD extrahepatic bile duct, CBD common bile duct, CVP cyclophosphamide, vincristine, prednisolone, CHOP cyclophosphamide, doxorubicin, vincristine, and prednisolone, CT computed tomography, ERCP endoscopic retrograde cholangiopancreatography, MRCP magnetic resonance cholangiopancreatography, MRI magnetic resonance imaging, PET positron emission tomography